Results 111 to 120 of about 15,205 (209)

Effects of LCZ696 (Sacubitril/Valsartan) on Blood Pressure in Patients with Hypertension: A Meta-Analysis of Randomized Controlled Trials [PDF]

, 2020
Qiang Geng, Rong-Qiang Yan, Zhengzhong Wang, Fangjie Hou   +3 more
openalex   +1 more source

Devastating Worsening Renal Function Following the Initiation of Sacubitril/Valsartan: Falling Between Two Stools [PDF]

, 2023
Akinori Sairaku, Yukiko Nakano
openalex   +1 more source

Congestion, decongestion, renal function and diuretics in (ESC) heart failure

ESC Heart Failure, Volume 12, Issue 2, Page 730-732, April 2025.
Jan Biegus, Piort Gajewski, Piotr Ponikowski   +2 more
wiley   +1 more source

Pharmacophore‐Based Identification and Molecular Characterization of Potent Neprilysin Inhibitors: Biochemical and Therapeutic Implications for Cardiovascular Diseases

Chemical Biology &Drug Design, Volume 107, Issue 2, February 2026.
Pharmacophore‐based virtual screening and molecular dynamics identified pentagalloylglucose and tannic acid as potent, non‐toxic neprilysin inhibitors. These natural compounds demonstrated strong binding affinity and stable interactions with the catalytic Zn2+ site, offering promising leads for cardiovascular drug development. ABSTRACT Neprilysin (NEP),
Chung‐Ting Kuo, Yi‐Chen Wu, Ji‐Min Li, Tz‐Chuen Ju, Tien‐Sheng Tseng   +4 more
wiley   +1 more source

The Benefits of Sacubitril–Valsartan in Patients with Acute Myocardial Infarction: A Systematic Review and Meta-Analysis

, 2021
Bo Xiong, Dan Nie, Jun Qian, Yuanqing Yao, Gang Yang, Shunkang Rong, Que Zhu, Yun Du, Yonghong Jiang, Jing Huang   +9 more
openalex   +1 more source

138 Matching the Uptake of Sacubitril/Valsartan to Heart Failure Prevalence in Australia [PDF]

, 2020
M. Kalsi, N. Dayawansa, V. Mutha
openalex   +1 more source

Mechanisms of action of sacubitril/valsartan on cardiac remodeling : a systems biology approach [PDF]

, 2017
Sacubitril/Valsartan, proved superiority over other conventional heart failure management treatments, but its mechanisms of action remains obscure. In this study, we sought to explore the mechanistic details for Sacubitril/Valsartan in heart failure and ...
Bayés-Genís, Antoni, Gálvez-Montón, Carolina, Iborra-Egea, Oriol, Perea-Gil, Isaac, Prat-Vidal, Cristina, Rudilla, F, Soler-Botija, Carolina, Universitat Autònoma de Barcelona   +7 more
core   +1 more source

Sacubitril/valsartan and isolated systolic hypertension in elderly patients: a prospective study

Известия высших учебных заведений. Поволжский регион: Медицинские науки
Background. The purpose of the research is to evaluate the antihypertensive efficacy of sacubitril/valsartan 200 mg/day compared with valsartan 160 mg/day in patients with grade 1–2 isolated systolic arterial hypertension (ISAH).
A.S. Ryazanov, M.V. Makarovskaya, N.A. Anisimov, L.V. Melnikova   +3 more
doaj   +1 more source

The evolution of guideline-directed medical therapy among decompensated HFrEF patients in sacubitril/valsartan era: Medical expenses and clinical effectiveness

, 2021
Huai-Wen Liang, Chia‐Te Liao, Wen-Yu Lin, Fa‐Po Chung, Jin‐Long Huang, Ying‐Hsiang Lee, Po-Lin Lin, Wei‐Ru Chiou, Chien‐Yi Hsu, Hung‐Yu Chang   +9 more
openalex   +1 more source

PCV100 Real-World IMPACT of Sacubitril/Valsartan on the Quality of Life of Heart Failure Patients in Portugal [PDF]

, 2020
Marta Afonso Nogueira, M. Afonso-Silva, M. Gomes, Valeska Andreozzi, B. Vandewalle, FAC Ferreira, Lurdes Mónica, Luciane Nascimento Cruz, Miguel Guimarães, Gonçalo Proença   +9 more
openalex   +1 more source